(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.12% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.6%.
Neogen's revenue in 2026 is $870,539,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2026 to be $190,413,846,076, with the lowest NEOG revenue forecast at $182,516,668,148, and the highest NEOG revenue forecast at $196,238,776,653. On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $187,962,847,634, with the lowest NEOG revenue forecast at $174,153,669,913, and the highest NEOG revenue forecast at $199,281,845,766.
In 2028, NEOG is forecast to generate $191,820,013,920 in revenue, with the lowest revenue forecast at $182,878,005,396 and the highest revenue forecast at $198,981,456,969.